Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: A Single Supplement of a Standardised Bilberry Extract Modifies Glycaemic Response [NA]
A completed clinical trial investigated whether a single supplement of standardized bilberry extract modifies glycemic response in individua…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Safety of NovoMix® 30 or Levemir® for Treatment of Type 2 Diabetics in Macedonia
This entry documents the completion of a clinical trial evaluating the safety of NovoMix 30 and Levemir in adults with Type 2 diabetes in Ma…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Observational Study on Levemir® in Obese Diabetic Patients
An observational study evaluating Levemir (insulin detemir) in obese patients with diabetes, including type 1 and type 2 diabetes; status is…
-
CLINICAL_TRIALS research · 2014-08-15Clinical Trial Update: OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA
AstraZeneca-sponsored clinical trial NCT01694758 on optimal Type 2 diabetes management in CEEMEA was completed, including benchmarking again…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 Diabetes
Observational study evaluating safety and efficacy of Levemir (insulin detemir) in Type 2 diabetes; the study status is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-08-15Clinical Trial Update: An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes
Observational study update on the efficacy and safety of Levemir (insulin detemir) in people with insulin-dependent type 1 or type 2 diabete…
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 44847 in Female and Male Patients With Type 2 Diabetes [Phase 1]
Phase 1 trial assessing safety, tolerability, pharmacokinetics and pharmacodynamics of multiple rising oral doses of BI 44847 in male and fe…
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating long-term effects of a DPP-4 inhibitor in type 2 diabetes mellitus; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: "Can Soluble-CD163 Discriminate Between Healthy and Unhealthy Obese Individuals?"
Completed clinical trial evaluating whether soluble-CD163 can discriminate between healthy and unhealthy obese individuals.
-
FDA label_change · 2014-08-12FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for BYETTA (exenatide) from AstraZeneca Pharmaceuticals LP, resulting in labeling changes for th…
-
CLINICAL_TRIALS trial_result · 2014-08-12Clinical Trial Update: A Pilot Study To Examine The Effects Of Ticagrelor To Protect Against Type 2 Diabetes-Induced Vascular Damage
A pilot clinical trial examines whether Ticagrelor can protect against vascular damage caused by type 2 diabetes mellitus in patients with s…
-
CLINICAL_TRIALS research · 2014-08-11Clinical Trial Update: Observational, Safety Study of NovoNorm® (Repaglinide) and Insulin Analogue Combination Therapy in Type 2 Diabetes in Korea
This document reports a completed observational safety study of combining NovoNorm (repaglinide) with an insulin analogue in adults with Typ…
-
CLINICAL_TRIALS trial_result · 2014-08-11Clinical Trial Update: Evaluation of a Self-management Oriented Diabetes Education Program for Intensified Insulin Therapy in Type 2 Diabetes [NA]
This update reports on a completed trial evaluating a self-management education program to support intensified insulin therapy in adults wit…
-
FDA approval · 2014-08-08FDA Approved: INVOKAMET — Original Application (Janssen Pharmaceuticals, Inc.)
FDA approved INVOKAMET, a fixed-dose combination of canagliflozin and metformin hydrochloride, through Janssen's original NDA.
-
CLINICAL_TRIALS trial_result · 2014-08-08Clinical Trial Update: Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating empagliflozin added to metformin in type 2 diabetes shows efficacy and safety; results posted.
-
CLINICAL_TRIALS trial_result · 2014-08-08Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 14332 CL as Tablet in Female and Male Patients With Type 2 Diabetes [Phase 1]
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamics study of multiple rising oral doses of BI 14332 CL in adults with Type 2…
-
CLINICAL_TRIALS trial_result · 2014-08-07Clinical Trial Update: 4 Week Treatment With Three Oral Doses of BI 10773 in Patients With Type 2 Diabetes [Phase 1]
This Phase 1 trial evaluated three oral doses of BI 10773 over four weeks in adults with type 2 diabetes; the study has completed and result…
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: Pharmacodynamics and Pharmacokinetics of Empagliflozin and Torasemide in Patients With Type 2 Diabetes [Phase 1]
Phase 1 pharmacodynamics and pharmacokinetics study of empagliflozin and torasemide in patients with Type 2 diabetes; results posted in 2014…
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Teneligliptin(MP-513) Versus Placebo in Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 trial comparing Teneligliptin (MP-513) to placebo in Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-04Clinical Trial Update: Glucagon-like Peptide (GLP) Utilization and Safety
This clinical trial update reports completion of a study evaluating the use and safety of glucagon-like peptide therapies in Type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2014-08-04Clinical Trial Update: Genetic Testing for Type 2 Diabetes [NA]
This clinical trial update summarizes results from a VA-sponsored study evaluating genetic testing for Type 2 diabetes. The trial status is …
-
FDA approval · 2014-08-01FDA Approved: JARDIANCE — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approves JARDIANCE (empagliflozin) as an original application for the treatment of type 2 diabetes mellitus.
-
FDA approval · 2014-08-01FDA Approved: GLIMEPIRIDE — Supplemental Application (Accord Healthcare Inc)
FDA approved a supplemental application for glimepiride from Accord Healthcare Inc, enabling the generic product to continue to be marketed.
-
CLINICAL_TRIALS research · 2014-08-01Clinical Trial Update: Mechanism Underlying Beta-cell Failure in Obese African Americans With History of Hyperglycemic Crises [NA]
A completed clinical trial update exploring the mechanism of beta-cell failure in obese African Americans with a history of hyperglycemic cr…
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: The Effects of Hypoglycaemia in People With Type 2 Diabetes [NA]
This trial update reports results from a completed study evaluating the effects of hypoglycaemia in people with Type 2 diabetes mellitus.